Joseph K. Schachle - 27 Nov 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role
Chief Operating Officer
Signature
/s/ Jessica Herron, by Power of Attorney
Issuer symbol
IRD
Transactions as of
27 Nov 2023
Net transactions value
$0
Form type
4
Filing time
27 Nov 2023, 18:24:19 UTC
Next filing
25 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Employee Stock Option (right to buy) Award $0 +300,000 $0.000000 300,000 27 Nov 2023 Common Stock 300,000 $2.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest with respect to 25% on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments on the last day of each full month over the subsequent 36 months, subject to continuing service.